QOP
Quinn Opportunity Partners Portfolio holdings
AUM
$1.16B
This Quarter Return
+9.44%
1 Year Return
+30.27%
3 Year Return
+47.92%
5 Year Return
+94.34%
10 Year Return
+147.84%
AUM
$1.16B
AUM Growth
+$1.16B
(-18%)
Cap. Flow
-$344M
Cap. Flow
% of AUM
-29.59%
Top 10 Holdings %
Top 10 Hldgs %
29.06%
Holding
436
New
49
Increased
73
Reduced
86
Closed
88
Top Buys
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$13.4M |
| 2 |
Mid-America Apartment Communities
MAA
|
$11.8M |
| 3 |
PG&E
PCG
|
$11.2M |
| 4 |
Interactive Brokers
IBKR
|
$10.6M |
| 5 |
Dick's Sporting Goods
DKS
|
$9.8M |
Top Sells
| 1 |
JNPR
Juniper Networks
JNPR
|
$29.9M |
| 2 |
CVS Health
CVS
|
$22.7M |
| 3 |
Microsoft
MSFT
|
$22.4M |
| 4 |
Netflix
NFLX
|
$21M |
| 5 |
BioNTech
BNTX
|
$18.4M |
Sector Composition
| 1 | Consumer Discretionary | 26.55% |
| 2 | Communication Services | 25.13% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 6.79% |
| 5 | Consumer Staples | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Anywhere Real Estate
HOUS
$684M
| $65K | 0.01% |
17,948
| – | – |
|
327
Green Plains
GPRE
$728M
| $60.9K | 0.01% |
10,100
| – | – |
|
328
CarParts.com
PRTS
$45.3M
| $59.5K | 0.01% |
80,436
-40,000
| -33% | -$29.6K |
|
329
Repare Therapeutics
RPTX
$71.7M
| $55.6K | ﹤0.01% |
+40,000
| New | +$55.6K |
|
|
NVX
330
NOVONIX
NVX
$237M
| $55.6K | ﹤0.01% |
55,000
| – | – |
|
331
Myriad Genetics
MYGN
$593M
| $53.1K | ﹤0.01% |
+10,000
| New | +$53.1K |
|
|
LAR
332
Lithium Argentina AG
LAR
$555M
| $49.6K | ﹤0.01% |
23,855
| – | – |
|
333
Lucid Motors
LCID
$6.08B
| $42.2K | ﹤0.01% |
20,000
-25,000
| -56% | -$52.8K |
|
334
Relay Therapeutics
RLAY
$619M
| $34.6K | ﹤0.01% |
+10,000
| New | +$34.6K |
|
335
Aquestive Therapeutics
AQST
$456M
| $33.4K | ﹤0.01% |
10,100
| – | – |
|
336
Conduent
CNDT
$439M
| $26.4K | ﹤0.01% |
10,000
| – | – |
|
337
Noodles & Co
NDLS
$33.1M
| $24.9K | ﹤0.01% |
35,000
| – | – |
|
338
Microvision
MVIS
$346M
| $22.8K | ﹤0.01% |
20,000
| – | – |
|
339
Fate Therapeutics
FATE
$120M
| $22.4K | ﹤0.01% |
+20,000
| New | +$22.4K |
|
340
AC Immune
ACIU
$205M
| $20.5K | ﹤0.01% |
10,100
| – | – |
|
341
Xcel Brands
XELB
$6.48M
| $18.1K | ﹤0.01% |
10,000
| – | – |
|
342
Vivid Seats
SEAT
$115M
| $16.9K | ﹤0.01% |
10,000
| – | – |
|
343
Fossil Group
FOSL
$165M
| $15.2K | ﹤0.01% |
10,301
| – | – |
|
|
FRSX
344
Foresight Autonomous Holdings
FRSX
$7.97M
| $9.78K | ﹤0.01% |
21,021
| – | – |
|
345
SPAR Group
SGRP
$28.2M
| $9.6K | ﹤0.01% |
10,000
| – | – |
|
346
Wolfspeed
WOLF
$194M
| $7.98K | ﹤0.01% |
20,000
-100,000
| -83% | -$39.9K |
|
347
Avis
CAR
$5.57B
| – | – |
-6,000
| Closed | -$455K |
|
348
uniQure
QURE
$896M
| – | – |
-64,000
| Closed | -$678K |
|
349
LiveRamp
RAMP
$1.83B
| – | – |
-83,000
| Closed | -$2.17M |
|
350
The RealReal
REAL
$879M
| – | – |
-1,023,237
| Closed | -$5.52M |
|